Erratum: Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study: Erratum
- PMID: 34805488
- PMCID: PMC8598217
- DOI: 10.1097/TXD.0000000000001259
Erratum: Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study: Erratum
Abstract
[This corrects the article DOI: 10.1097/TXD.0000000000001166.].
© 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Erratum for
-
Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study.Transplant Direct. 2021 Jul 9;7(8):e722. doi: 10.1097/TXD.0000000000001166. eCollection 2021 Aug. Transplant Direct. 2021. PMID: 34263020 Free PMC article.
References
-
- Friman S, Tisone G, Nevens F, et al. . Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study. Transplantation Direct. 2021;7(8):e722; doi: 10.1097/TXD.0000000000001166. Published online July 9, 2021. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources